Model
Edge
BioCryst Pharmaceuticals Inc
0001760020
Filing Type
4
Filing Date
3/3/2024
Updated
3/4/24, 9:32 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership